Genpact FY2024 revenue rises 6.5% to $4.77 billion; GAAP EPS falls 16% to $2.85
Genpact reported full-year 2024 net revenues of $4.77 billion, up 6.5%, and adjusted diluted EPS of $3.28, up 10%. GAAP diluted EPS fell 16% to $2.85 and net income fell 19% to $514 million, with the 2023 comparison including a $170 million non-recurring tax benefit. The company also raised its quarterly dividend 11% to $0.17 and added $500 million to its share repurchase authorization, and it guided to 2025 adjusted diluted EPS of $3.52 to $3.59.
Key points
- Full-year 2024 net revenues were $4.77 billion, up 6.5%; fourth-quarter net revenues were $1.25 billion, up 8.9%
- Diluted EPS was $2.85, down 16%; adjusted diluted EPS was $3.28, up 10%
- 2025 outlook: net revenues of $5.029 billion to $5.125 billion and adjusted diluted EPS of $3.52 to $3.59
- Quarterly dividend raised to $0.17 per share (11% increase), payable March 26, 2025; repurchase authorization increased by $500 million
The filing
Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 06, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.